Cargando…

Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review

Primary Sjogren’s syndrome is a chronic autoimmune disease with glandular and extraglandular features. Renal involvement is less frequent when compared with other systemic manifestations. Glomerulonephritis is a relatively rare manifestation of primary Sjogren’s syndrome. Among all types of glomerul...

Descripción completa

Detalles Bibliográficos
Autores principales: Şule Yaşar Bilge, Nazife, Özkurt, Sultan, Fuat Açıkalın, Mustafa, Kaşifoğlu, Timuçin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mesut Onat 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089134/
https://www.ncbi.nlm.nih.gov/pubmed/36052636
http://dx.doi.org/10.5152/eurjrheum.2022.20246
_version_ 1785022705282580480
author Şule Yaşar Bilge, Nazife
Özkurt, Sultan
Fuat Açıkalın, Mustafa
Kaşifoğlu, Timuçin
author_facet Şule Yaşar Bilge, Nazife
Özkurt, Sultan
Fuat Açıkalın, Mustafa
Kaşifoğlu, Timuçin
author_sort Şule Yaşar Bilge, Nazife
collection PubMed
description Primary Sjogren’s syndrome is a chronic autoimmune disease with glandular and extraglandular features. Renal involvement is less frequent when compared with other systemic manifestations. Glomerulonephritis is a relatively rare manifestation of primary Sjogren’s syndrome. Among all types of glomerular manifestations, minimal change disease is rarely identified, and there are only a few cases in the literature. Herein, we present a 53-year-old male patient who was diagnosed with primary Sjogren’s syndrome and minimal change disease while searching for the etiopathogenesis of nephrotic syndrome. The patient had edema, dyspnea, hypertension, and 12 g/day proteinuria at admission. Serum albumin level was 1.82 g/dL, and renal function tests were within normal ranges. Renal biopsy findings were consistent with minimal change disease. At the same time, he was diagnosed with primary Sjogren’s syndrome based on dry eyes demonstrated with Schirmer’s test, positive antinuclear antibody, anti-SS-A, and anti-SS-B antibodies. Hydroxychloroquine with methylprednisolone 1 mg/kg (64 mg/day) was started, and methylprednisolone was slowly tapered. His proteinuria regressed to 79.2 mg/day, creatinine level was 0.83 mg/dL, and serum albumin level increased to 3.88 g/dL on the second week of the glucocorticoid treatment. In this case-based review, we present our case with 5 other reports of minimal change disease associated with primary Sjogren’s syndrome. Our aim was to increase the awareness of this rare concurrence both among rheumatologists and nephrologists in light of the literature review.
format Online
Article
Text
id pubmed-10089134
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mesut Onat
record_format MEDLINE/PubMed
spelling pubmed-100891342023-04-12 Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review Şule Yaşar Bilge, Nazife Özkurt, Sultan Fuat Açıkalın, Mustafa Kaşifoğlu, Timuçin Eur J Rheumatol Case based Review Primary Sjogren’s syndrome is a chronic autoimmune disease with glandular and extraglandular features. Renal involvement is less frequent when compared with other systemic manifestations. Glomerulonephritis is a relatively rare manifestation of primary Sjogren’s syndrome. Among all types of glomerular manifestations, minimal change disease is rarely identified, and there are only a few cases in the literature. Herein, we present a 53-year-old male patient who was diagnosed with primary Sjogren’s syndrome and minimal change disease while searching for the etiopathogenesis of nephrotic syndrome. The patient had edema, dyspnea, hypertension, and 12 g/day proteinuria at admission. Serum albumin level was 1.82 g/dL, and renal function tests were within normal ranges. Renal biopsy findings were consistent with minimal change disease. At the same time, he was diagnosed with primary Sjogren’s syndrome based on dry eyes demonstrated with Schirmer’s test, positive antinuclear antibody, anti-SS-A, and anti-SS-B antibodies. Hydroxychloroquine with methylprednisolone 1 mg/kg (64 mg/day) was started, and methylprednisolone was slowly tapered. His proteinuria regressed to 79.2 mg/day, creatinine level was 0.83 mg/dL, and serum albumin level increased to 3.88 g/dL on the second week of the glucocorticoid treatment. In this case-based review, we present our case with 5 other reports of minimal change disease associated with primary Sjogren’s syndrome. Our aim was to increase the awareness of this rare concurrence both among rheumatologists and nephrologists in light of the literature review. Mesut Onat 2022-10-01 /pmc/articles/PMC10089134/ /pubmed/36052636 http://dx.doi.org/10.5152/eurjrheum.2022.20246 Text en 2022 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Case based Review
Şule Yaşar Bilge, Nazife
Özkurt, Sultan
Fuat Açıkalın, Mustafa
Kaşifoğlu, Timuçin
Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
title Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
title_full Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
title_fullStr Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
title_full_unstemmed Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
title_short Minimal Change Disease and Primary Sjogren Syndrome Concurrence: Case-Based review
title_sort minimal change disease and primary sjogren syndrome concurrence: case-based review
topic Case based Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089134/
https://www.ncbi.nlm.nih.gov/pubmed/36052636
http://dx.doi.org/10.5152/eurjrheum.2022.20246
work_keys_str_mv AT suleyasarbilgenazife minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview
AT ozkurtsultan minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview
AT fuatacıkalınmustafa minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview
AT kasifoglutimucin minimalchangediseaseandprimarysjogrensyndromeconcurrencecasebasedreview